You searched for Parkinson's - Page 13 of 19

Best in Biotech 15 Mar 2023

10 immunotherapy companies making waves in 2023

…diseases like Parkinson’s. ElevateBio is looking to develop iPSC-derived therapies, for which it set up a new company in 2022, in a collaborative effort with Boston Children’s Hospital, where it…

March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 8 May 2020

Phase III Failure Sinks Drug for Rare Neurological Disorder

…licensed from Merck KGaA after it failed phase III trials for Parkinson’s disease — had been billed as the first therapy to become independently commercialized by Newron. Adding to the…

May 8, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 13 Sep 2022

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

…4,000 human diseases including Alzheimer’s disease, Parkinson’s disease, cystic fibrosis, cardiovascular disease, Duchenne muscular dystrophy, and some types of cancer, originate from errors and changes in an individual’s DNA sequence….

September 13, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 28 Jan 2020

10 Scientists Behind Modern Biotech You Probably Don’t Know

…treatments for sickle-cell anemia and Parkinson’s disease using these cells. Françoise Barré-Sinoussi (born 1947) Francois Barre-Sinoussi, 2012 – International AIDS Conference in Washington DC. Photo credit: Michael Fleshman Françoise Barré-Sinoussi…

January 28, 2020 - 8 minutesmins - By Helen Albert

News and Trends 11 Jan 2023

We DUB this target ‘druggable’

…cellular health and longevity. Recently presented at the 2022 Society for Neuroscience (SfN) conference, new data from the Beth Israel Deaconess Medical Center (BIDMC) cements Parkinson’s disease (PD) as a…

January 11, 2023 - 5 minutesmins - By External Contributor

Best in Biotech 2 Apr 2024

Chicago biotech: Seven players advancing the industry

…diseases. Their lead program is VQ-101, a small molecule designed to activate glucocerebrosidase (GCase), particularly targeting Parkinson’s disease (PD) and Dementia with Lewy Bodies (DLB), a type of progressive dementia…

April 2, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

…such as certain cancers and neurodegenerative diseases like Huntington’s and Parkinson’s. The Italian biotech’s pipeline includes several FID-based candidates targeting various therapeutic areas but its pipeline is still preclinical. Its…

August 22, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 6 Oct 2022

15 biotech companies shaking up the scene in Cambridge

…and Parkinson’s disease. The company currently has six programs in its pipeline, four in-house programs in research and preclinical phases and two undisclosed partnered programs with AbbVie and Pfizer. Last…

October 6, 2022 - 9 minutesmins - By Helen Albert

In Depth 29 May 2018

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

…mental illnesses as well as neurodegenerative disorders such as Parkinson’s and Alzheimer’s. Closely linked with the microbiome is research into metabolism. “This is not yet an area sufficiently mainstream, but…

May 29, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Startup Scout 10 May 2019

This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins

…on the case, discovering new leads that could degrade proteins involved in Alzheimer’s and Parkinson’s disease. Sandham told me that Polyprox could enter the neurodegenerative disease space with a potential…

May 10, 2019 - 4 minutesmins - By Jonathan Smith

biotech stock price euronext genmab argenx

News and Trends 25 May 2021

Delayed IPOs and Market Drops Batter Biotech Stocks

…the Netherlands and bluebird bio in the US, gene therapy trials were paused to investigate cancer cases in a few patients. A trial of a Parkinson’s disease gene therapy developed…

May 25, 2021 - 6 minutesmins - By Jonathan Smith

som biotech huntingtons disease repurpose amyloidosis

Startup Scout 29 Mar 2019

This Biotech Repurposes Drugs to Fight Huntington’s Disease

…Benevolent AI repurposing treatments for Parkinson’s disease. However, Insa told me that SOM Biotech’s technology is three times better at predicting suitable drugs than competitor companies. The company identified an…

March 29, 2019 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

10 immunotherapy companies making waves in 2023

Phase III Failure Sinks Drug for Rare Neurological Disorder

WhiteLab Genomics raises $10M for AI-powered genomic therapies platform

10 Scientists Behind Modern Biotech You Probably Don’t Know

We DUB this target ‘druggable’

Chicago biotech: Seven players advancing the industry

Seven companies transforming the biotech industry in Italy

15 biotech companies shaking up the scene in Cambridge

Clinical Trials in Alzheimer’s Disease Are Failing: What Can Be Done?

This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins

Delayed IPOs and Market Drops Batter Biotech Stocks

This Biotech Repurposes Drugs to Fight Huntington’s Disease

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!